Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568087 · ClinicalTrials.gov registry record · Phase 1
N-acetylcysteine in Alcohol Dependence
A Phase 1 study of Alcoholism, sponsored by Minneapolis Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT00568087: Completed Phase 1 study of Alcoholism, sponsored by Minneapolis Veterans Affairs Medical Center.
NCT00568087 is a Phase 1 study of Alcoholism that has completed, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 46 participants, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568087, a Phase 1 study of Alcoholism, has completed, sponsored by Minneapolis Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The present study is designed to find out if N-acetylcysteine works in reducing alcohol drinking and craving.
Primary Outcome
The percentage of heavy drinking days was primary a priori outcome measure. Heavy drinking was defined as ≥ 5 standard drinks per day for men and ≥ 4 standard drinks for women. One standard drink is any drink containing about 0.6 fluid ounces or 14 grams of pure alcohol. The percentage of heavy drinking days (HDD) was measured at each weekly visit during the 8 weeks--from week 1 (before starting intervention) to week 9 (after completing intervention). At each week, the percentage of HDD was calc
Conditions Studied
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine
Study Locations (1)
Minnesota
- Minneapolis VA Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
What the finished NCT00568087 record still lists
NCT00568087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Alcoholism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00568087 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00568087 about?
NCT00568087 is a clinical study titled "N-acetylcysteine in Alcohol Dependence". The present study is designed to find out if N-acetylcysteine works in reducing alcohol drinking and craving.
What is the current status of trial NCT00568087?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2007-12. Estimated completion is 2009-08.
What conditions does trial NCT00568087 study?
This clinical trial studies the following conditions: Alcoholism.
What interventions are being tested in trial NCT00568087?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT00568087?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00568087 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00568087's enrollment target sits among peer trials
46 53rd of 65 higher than 13 of 65 other Alcoholism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcoholism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
COMPLETED · Phase 1
-
A Novel Compound for Alcoholism Treatment
COMPLETED · Phase 1
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
COMPLETED · Phase 1
-
GSK1521498 Alcohol Interaction Study
COMPLETED · Phase 1
-
Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment
COMPLETED · Phase 1
-
Matching Genotypes and Serotonergic Medications for Alcoholism
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia